Marius M. Hoeper (Hannover, Germany), John Wort (Hampton, United Kingdom)
Assessment of platelet dysfunction in patients with pulmonary arterial hypertension
Iraklis Tsagkaris (Athens, Greece), Eleni Vrigkou, Argiris Tsantes, Stefanos Bonovas, Anastasia Anthi, Dimitris Konstantonis, Athanasios Pappas, Cornelia Mitrakou, Stelios Orfanos, Apostolos Armaganidis, Iraklis Tsagkaris
|   |
Native myocardial T1 correlates with right ventricular remodelling in patients with pulmonary hypertension
Laura Saunders (Hope Valley, United Kingdom), Laura Hutchison, Neil Stewart, Charlotte Hammerton, David Capener, Valentina Puntmann, Kiely David, Wild Jim, Swift Andy
| |
Management of selexipag interruptions in the GRIPHON study
Ioana R Preston (Boston, United States of America), Ioana Preston, Kelly Chin, Lilla Di Scala, Harrison Farber, Sean Gaine, Nazzareno Galiè, Hossein-Ardeschir Ghofrani, Marius M. Hoeper, Irene Lang, Vallerie McLaughlin, Ralph Preiss, Lewis J. Rubin, Gérald Simonneau, Olivier Sitbon, Victor F Tapson, Richard Channick
| |
Dysregulation of iron homeostasis in Eisenmenger syndrome; comparison to idiopathic pulmonary arterial hypertension and healthy controls
Sharon Mumby (London, United Kingdom), Sharon Mumby, Latha Ramakrishnan, Aleksander Kempny, Gregory Quinlan, John Wort
| |
Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis. A tissue doppler imaging study
Michele D'Alto (Naples, Italy), Michele D’alto, Paola Argiento, Giovanni Maria De Matteis, Antonella Marcoccia, Anna Correra, Emanuele Romeo, Giovanni Maria Di Marco, Rosaria Irace, Antonella Riccardi, Maria Giovanna Russo, Gabriele Valentini
| |
Echocardiography for the diagnosis of pulmonary vascular disease
Michele D'Alto (Naples, Italy), Michele D’alto, Emanuele Romeo, Paola Argiento, Adriana Pavelescu, Giovanni Maria Di Marco, Agostino Mattera Iacono, Anna Correra, Maria Giovanna Russo, Robert Naeije
| |
Right ventricular MRI characteristics in patients with borderline pulmonary hypertension
Kieran Shotton (Sheffield, United Kingdom), Kieran Shotton, Henry Walker, Christopher Johns, Dave Capener, Charlie Elliot, Robin Condliffe, Thanos Charalampopoulos, David Kiely, Jim Wild, Andrew Swift
| |
Echocardiography for defining the right ventricular contractile reserve in healthy subjects
Michele D'Alto (Naples, Italy), Michele D’alto, Adriana Pavelescu, Emanuele Romeo, Paola Argiento, Giovanni Maria Di Marco, Anna Correra, Agostino Mattera Iacono, Maria Giovanna Russo, Robert Naeije
| |
Vasoreactivity to inhaled nitric oxide does not predict long term survival in pulmonary arterial hypertension
Geeshath Jayasekera (Glasgow, United Kingdom), Geeshath Jayasekera, Martin Johnson, Colin Church, Andrew Peacock
| |
Role of tadalafil in patients with hypoxia / lung disease induced (group 3) pulmonary hypertension
Suraj Puthiyaveettil (Kozhikode, India), Suraj Puthiyaveettil, Jyothi Edakalavan
| |
Dexamethasone reduces pulmonary artery pressure in lowlanders with COPD travelling to 3200m. A randomized, placebo-controlled trial
Mona Lichtblau (Heidelberg, Germany), Mona Lichtblau, Michael Furian, Sayaka Aeschbacher, Maya Bisang, Sara Hartmann, Stefanie Ulrich, Tsogyal Latshang, Almaz Aldashev, Erkin Mirrakhimov, Talant Soronbaev, Konrad E. Bloch, Silvia Ulrich
| |
Iron deficiency in pulmonary arterial hypertension: A matter of definition!
Thomas Sonnweber (Innsbruck, Austria), Thomas Sonnweber, Eva Rieger, Katharina Cima, Günter Weiss, Judith Löffler-Ragg
| |
Inhaled glucocorticosteroid treatment effects on pulmonary artery pressure and cardiac function in healthy smokers
Eliana Mendes (Miami, FL, United States of America), Eliana Mendes, Adam Wanner, Meela Parker, Andreas Schmid, Johana Arana, Barry Hurwitz
| |
The OPTIEK1 study: Design and preliminary results of a Dutch national registry
Anna Huis in 't Veld (Amsterdam, Netherlands), Anna Huis in ’t Veld, A. Vonk Noordegraaf, A. Boonstra, W. Jacobs, H.M. Willemsen, H.P. Grotjohan, W.M. Waskowsky, M.J. Overbeek, S.A. Mollema, L.H. Elbouazzaoui, J.W.J. Vriend, R. Hoekstra, J. Van der Maten, A.P. Van der Weerdt, H.J. Bogaard
| |
MRI derived left atrial volume index predicts treatment response in patients with PAH
Euan Tubman (Sheffield, United Kingdom), Euan Tubman, Tom Sproson, Dave Capener, Robin Condliffe, Charlie Elliot, Athanasios Charalampopolous, David Kiely, Wild Jim, Andy Swift
| |
Procedural safety of a fully implantable pump for delivery of intravenous prostanoids in severe pulmonary hypertension: A two-center observational study
Manuel Richter (Bad Nauheim, Germany), Manuel Richter, Ralf Ewert, Christian Warnke, Henning Gall, Simon Classen, Friedrich Grimminger, Eckhard Mayer, Werner Seeger, Ardeschir Ghofrani
| |
Cardiopulmonary MR characteristics can estimate mPAP in COPD
Christopher Johns (Sheffield, United Kingdom), Christopher Johns, Dave Capener, Charlotte Hammerton, Kieran Shotton, Charlie Elliot, Robin Condliffe, David Kiely, Jim Wils, Andrew Swift
| |
Clinical manifestation of hereditary pulmonary arterial hypertension by a ²second hit² mutation in the genes BMPR2 and EIF2AK4
Christina Eichstaedt (Heidelberg, Germany), Christina Eichstaedt, Jie Song, Rebecca Rodríguez Viales, Nicola Benjamin, Satenik Harutyunova, Christine Fischer, Katrin Hinderhofer, Ekkehard Grünig
| |